DP303c Injection

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DP303c Injection, covering 2021-04-01 to 2021-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of DP303c Injection in Patients With Advanced Ovarian Cancer [Phase 2]